Abstract:Objective There are numerous reasons for short stature, including mutations in osteochondral development genes. ACAN, one such osteochondral development gene in which heterozygous mutations can cause short stature, has attracted attention from researchers in recent years. Therefore, we analyzed six cases of short stature with heterozygous ACAN mutations and performed a literature review. Methods Clinical information and blood samples from 6 probands and their family members were collected after consent forms were signed. Gene mutations in the probands were detected by whole-exome sequencing. Then, we searched the literature, performed statistical analyses, and summarized the characteristics of all reported cases. Results We identified six novel mutations in ACAN: c.1411C>T, c.1817C>A, c.1762C>T, c.2266G>C, c.7469G>A, and c.1733-1G>A. In the literature, more than 200 affected individuals have been diagnosed genetically with a similar condition (height standard deviation score [SDS] -3.14 ± 1.15). Among affected individuals receiving growth-promoting treatment, their height before and after treatment was SDS -2.92 ± 1.07 versus SDS -2.14 ± 1.23 (P<.001). As of July 1, 2019, a total of 57 heterozygous ACAN mutations causing nonsyndromic short stature had been reported, including the six novel mutations found in our study. Approximately half of these mutations can lead to protein truncation. Conclusions This study used clinical and genetic means to examine the relationship between the ACAN gene and short stature. To some extent, clear diagnosis is difficult, since most of these affected individuals’ characteristics are not prominent. Growth-promoting therapies may be beneficial for increasing the height of affected patients. Abbreviations: AI = aromatase inhibitor; ECM = extracellular matrix; GnRHa = gonadotropin-releasing hormone analogue; IQR = interquartile range; MIM = Mendelian Inheritance in Man; PGHD = partial growth hormone deficiency; rhGH = recombinant human growth hormone; SDS = standard deviation score; SGA = small for gestational age; SGHD = severe growth hormone deficiency

Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short stature

The molecular genetics of growth hormone deficiency

Long-Term Efficacy and Safety of Recombinant Human Growth Hormone in Children Born Small for Gestational Age.

A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway

Genetic Characterization of Short Stature Patients With Overlapping Features of Growth Hormone Insensitivity Syndromes

Three New Mutations in the Gene for the Growth Hormone (Gh)-Releasing Hormone Receptor in Familial Isolated Gh Deficiency Type Ib

The clinical and genetic aspects of six individuals with GH1 variants and isolated growth hormone deficiency type II

Growth-Promoting Therapies May Be Useful in Short Stature Patients with Nonspecific Skeletal Abnormalities Caused by Acan Heterozygous Mutations: Six Chinese Cases and Literature Review

Genetic variations at the human growth hormone receptor (GHR) gene locus are associated with idiopathic short stature

Genetic Polymorphisms Associated with Idiopathic Short Stature and First-Year Response to Growth Hormone Treatment

Detection of GH1 Gene Mutation in Patients with Familial Short Stature

Whole Exome Sequencing Uncovered the Genetic Architecture of Growth Hormone Deficiency Patients

Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone

Isolated Growth Hormone (gh) Deficiency Due to Compound Heterozygosity for Two New Mutations in the Gh-Releasing Hormone Receptor Gene

Correlation of Growth Hormone Receptor and Its Signal Pathway Defects with the Phenotype: A Study of 21 Cases with Growth Hormone Insensitivity Syndrome

Clinical characteristics of and growth hormone treatment effects on short stature with type 1 insulin-like growth factor receptor (IGF1R) gene alteration

Molecular diagnosis for growth hormone deficiency in Chinese children and adolescents and evaluation of impact of rare genetic variants on treatment efficacy of growth hormone

Molecular diagnosis is an important indicator for response to growth hormone therapy in children with short stature

Clinical Characteristics of Short-Stature Patients With an NPR2 Mutation and the Therapeutic Response to rhGH.

Two years in growth hormone 2017-18

Mortality in Children Receiving Growth Hormone Treatment of Growth Disorders: Data From the Genetics and Neuroendocrinology of Short Stature International Study